Speaker illustration

Doctor Narek Tmoyan

National Medical Research Center of Cardiology, Moscow (Russian Federation)

Member of:

European Society of Cardiology

Elevated lipoprotein(a) level predicts repeated peripheral revascularization

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Peripheral Vascular and Cerebrovascular Disease ePosters

Thumbnail

Role of lipoprotein(a) and its autoantibodies in polyvascular atherosclerotic disease

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Biomarkers

Session: Risk Factors and Prevention ePosters

Thumbnail

Obesity paradox, hyperlipoproteinemia(a), autotaxin concentration and stenotic atherosclerosis of different vascular territories

Event: ESC CONGRESS 2019

Topic: Obesity

Session: Obesity

Thumbnail

Lipoprotein(a) and clinical outcomes in patients after revascularization of peripheral arteries

Event: ESC CONGRESS 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Advances in peripheral arterial disease

Thumbnail

Elevated lipoprotein(a) as a predictor of peripheral artery diseases

Event: ESC Congress 2018

Topic: Lipids, Other

Session: Preventive cardiology / Lipids

Thumbnail

Lipoprotein(a) is a marker of peripheral artery disease in the absence of coronary heart disease.

Event: ESC CONGRESS 2017

Topic: Pathophysiology, epidemiology

Session: Vascular diseases

Thumbnail

This platform is supported by

logo Novo Nordisk